Stay updated with breaking news from Vortex Analytics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
As a new generation of amateur share traders pile into stocks and threaten a revolution on Wall Street, company bosses on this side of the Atlantic have been selling out.Directors in UK-listed
Hedge funds profit from AstraZeneca fall, but FTSE short sellers face continued challenges in 2021 Submitted By Hugh Leask | 06/01/2021 - 4:02pm Hedge funds have made gains from bets against AstraZeneca and GlaxoSmithKline in recent weeks – but bearish managers lost more than USD600 million on FTSE 100 shorts at the end of the year, with short sellers facing continuing “unpredictable swings” in 2021. Short positions in AstraZeneca – whose Covid-19 vaccine developed alongside Oxford University began rolling out in the UK this week – brought in almost GBP13 million for bearish hedg...
Imagine having the chance a few years ago to buy a company that is, today, worth over $600 billion (and counting) at one-tenth of its current value. Sounds like a dream offer, right? Who would skip out on that? That would be Apple, another company that is at the peak of its success.
Tesla enters S&P 500: Here's how the stock did on its first day Ines Ferré Tesla’s (TSLA) long awaited entry into the S&P 500 (^GSPC) got off on a soft note, with the stock tumbling by over 5% in tandem with a broader move lower in markets. Markets swooned on Monday, tracking declines in European and Asian equities as concerns mounted over a new infectious strain of the coronavirus identified in the UK. The move drove all risk-sensitive assets lower in early dealings. By market close, stocks had recovered though Tesla was still down over 6%. Nevertheless, the longer-term s...